We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 54 start-ups with an aggregate funding of $4.9b. The average funding per company in this subset is $90.9m.
Last update to the database: Feb 18, 2025. See changelog.
A genetic medicine company that build data platforms using synthetic biology, artificial intelligence and genetic medicine for the development of medical therapies.
5
Funding Rounds
$236.7m
Money raised
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
Silicon Valley-based genetic engineering startup.
8
Funding Rounds
$459.7m
Money raised
Nextbiotics is a biotechnology and synthetic biology company that leverages synthetic biology tools and bacteriophage technology to provide solutions to the antibiotic resistance crisis.
1
Funding Rounds
$750.0k
Money raised
DNA synthesis company using enzymatic DNA synthesis based in San Francisco.
4
Funding Rounds
$87.8m
Money raised
SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.
1
Funding Rounds
$10.5m
Money raised
Integrated DNA Technologies is a Coralville, Iowa-based company founded in 1987.
1
Funding Rounds
Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
3
Funding Rounds
$109.0m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
2
Funding Rounds
$645.0k
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
Agriculture company developing novel methods of pest control
2
Funding Rounds
$170.0m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
11
Funding Rounds
$37.9m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
9
Funding Rounds
$59.1m
Money raised
A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.
1
Funding Rounds
$2.0m
Money raised
A life sciences and genomics organization. It was founded in 1999 and is located in Shenzhen, China.
1
Funding Rounds
$284.8m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
2
Funding Rounds
$2.6m
Money raised
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013.
2
Funding Rounds
$122.8m
Money raised
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
1
Funding Rounds
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
4
Funding Rounds
$343.1m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
1
Funding Rounds
$2.5m
Money raised
Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality.
2
Funding Rounds
$160.0m
Money raised
Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.
1
Funding Rounds
$1.2m
Money raised
Vineti is a cloud-based cell-therapy management system founded in 2016 by Razmik Abnous.
6
Funding Rounds
$152.3m
Money raised
Calimmune is a biotechnology company developing gene and stem cell therapies for treating rare and serious diseases.
1
Funding Rounds
$15.9m
Money raised
AAVANTIBio is a biotechnology company developing gene therapies.
2
Funding Rounds
$213.9m
Money raised
iVexSol is a newly formed viral vector manufacturing company
2
Funding Rounds
$15.0m
Money raised
Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.
4
Funding Rounds
$3.3m
Money raised
StrideBio is a Durham, North Carolina-based company.
3
Funding Rounds
$97.2m
Money raised
Apic Bio is a gene Therapy founded in 2017 by John Reilly.
5
Funding Rounds
$70.7m
Money raised
Zbiotics is a company creating genetically engineered probiotics for consumers founded in 2016 by Zachary Abbott.
1
Funding Rounds
$2.3m
Money raised
Kriya Therapeutics is a gene Therapy founded in 2019 by Shankar Ramaswamy, J. Fraser Wright and Roger Jeffs.
3
Funding Rounds
$455.6m
Money raised
ElevateBio is a company founded by Vikas Sinha, David Hallal and Melissa Carpenter.
2
Funding Rounds
$695.0m
Money raised
Limelight Bio is a biopharmaceutical company researching and developing novel gene therapy technologies.
3
Funding Rounds
$139.0m
Money raised
Xalud Therapeutics is a neuropathic pain therapies.
2
Funding Rounds
$55.2m
Money raised
Renova Therapeutics is a company that envisions a future where it can permanently treat chronic diseases
2
Funding Rounds
$7.5m
Money raised
Kolon TissueGene is a biotechnology company developing cell and gene therapies for treating osteoarthritis.
2
Funding Rounds
$59.7m
Money raised
Cyagen Biosciences is a Santa Clara, California-based biotechnology company providing rodent models, viral vector development, CAR design and construction, disease models, phenotype analysis, pharmacodynamic evaluations, and stem cell products for cell and gene therapy research.
1
Funding Rounds
$41.0m
Money raised
CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.
2
Funding Rounds
$34.0m
Money raised
Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases.
3
Funding Rounds
$16.1m
Money raised
Hemera Biosciences is a treatment for dry macular degeneration company founded in 2010 by Jay S. Duker, Elias Reichel and Adam Rogers.
1
Funding Rounds
$1.3m
Money raised
InnoSkel is a therapies for Rare Skeletal Diseases founded in 2020 by Elvire Gouze.
2
Funding Rounds
$44.0m
Money raised
Ring Therapeutics is a multi-product platform company.
2
Funding Rounds
$167.0m
Money raised
XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
2
Funding Rounds
$58.9m
Money raised
Lysogene is a company by Karen Aiach.
1
Funding Rounds
$16.5m
Money raised
Nuntius Therapeutics is a cell-specific DNA, RNA and CRISPR therapies founded in 2021 by Albert Kwok.
1
Funding Rounds
$130.0k
Money raised
Gene therapies developer for pediatric patients.
1
Funding Rounds
$52.0m
Money raised
Eden Bio is a machine Learning to Guide Genetic Engineering founded in 2021.
$1.2m
Money raised
Myosana Therapeutics is a non-viral Gene Therapy founded in 2018.
1
Funding Rounds
$1.0m
Money raised
Gracell is a China-based company founded in 2017.
1
Funding Rounds
$85.0m
Money raised
Ikarovec is an ocular Gene Therapy founded in 2018.
1
Funding Rounds
$3.3m
Money raised
Gyroscope Therapeutics Ltd is a United Kingdom-based company founded in 2016.
2
Funding Rounds
$205.7m
Money raised
Zbiotics Co is a San Francisco-based company founded in 2016.
1
Funding Rounds
$5.7m
Money raised